{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T03:58:11Z","timestamp":1790222291896,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.clgc.2019.12.010","type":"journal-article","created":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T20:42:49Z","timestamp":1576269769000},"page":"e391-e396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["METastasis Reporting and Data System for Prostate Cancer as a Prognostic Imaging Marker in Castration-resistant Prostate Cancer"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2757-8083","authenticated-orcid":false,"given":"Soichiro","family":"Yoshida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Takahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikako","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5285-0352","authenticated-orcid":false,"given":"Yuki","family":"Arita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuma","family":"Waseda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4380-9294","authenticated-orcid":false,"given":"Toshiki","family":"Kijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minato","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichiro","family":"Ishioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoh","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutaka","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhisa","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2019.12.010_bib1","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/j.1742-1241.2011.02799.x","article-title":"Characterising the castration-resistant prostate cancer population: a systematic review","volume":"65","author":"Kirby","year":"2011","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.clgc.2019.12.010_bib2","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.eururo.2016.08.002","article-title":"EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: treatment of relapsing, metastatic, and castration-resistant prostate cancer","volume":"71","author":"Cornford","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2019.12.010_bib3","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/j.ejca.2014.07.002","article-title":"Monitoring the response of bone metastases to treatment with magnetic resonance imaging and nuclear medicine techniques: a review and position statement by the European Organisation for Research and Treatment of Cancer imaging group","volume":"50","author":"Lecouvet","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clgc.2019.12.010_bib4","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.eururo.2017.03.042","article-title":"Diagnostic performance of magnetic resonance imaging for the detection of bone metastasis in prostate cancer: a systematic review and meta-analysis","volume":"73","author":"Woo","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2019.12.010_bib5","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/jmri.22608","article-title":"Diagnostic value of whole-body magnetic resonance imaging for bone metastases: a systematic review and meta-analysis","volume":"34","author":"Wu","year":"2011","journal-title":"J\u00a0Magn Reson Imaging"},{"key":"10.1016\/j.clgc.2019.12.010_bib6","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/jmri.25196","article-title":"Diffusion-weighted imaging outside the brain: Consensus statement from an ISMRM-sponsored workshop","volume":"44","author":"Taouli","year":"2016","journal-title":"J\u00a0Magn Reson Imaging"},{"key":"10.1016\/j.clgc.2019.12.010_bib7","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.mri.2011.02.029","article-title":"Improving background suppression in diffusion-weighted imaging of the abdomen and pelvis using STIR with single-axis diffusion encoding","volume":"29","author":"Kwee","year":"2011","journal-title":"Magn Reson Imaging"},{"key":"10.1016\/j.clgc.2019.12.010_bib8","first-page":"275","article-title":"Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display","volume":"22","author":"Takahara","year":"2004","journal-title":"Radiat Med"},{"key":"10.1016\/j.clgc.2019.12.010_bib9","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ejrad.2009.03.054","article-title":"Whole-body diffusion-weighted magnetic resonance imaging","volume":"70","author":"Kwee","year":"2009","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.clgc.2019.12.010_bib10","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1007\/s00330-008-0968-z","article-title":"Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology","volume":"18","author":"Kwee","year":"2008","journal-title":"Eur Radiol"},{"key":"10.1016\/j.clgc.2019.12.010_bib11","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.eururo.2012.02.020","article-title":"Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer?","volume":"62","author":"Lecouvet","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2019.12.010_bib12","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.eururo.2014.07.020","article-title":"Impact of the site of metastases on survival in patients with metastatic prostate cancer","volume":"68","author":"Gandaglia","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2019.12.010_bib13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.eururo.2016.05.033","article-title":"METastasis Reporting and Data System for Prostate Cancer: practical guidelines for acquisition, interpretation, and reporting of whole-body magnetic resonance imaging-based evaluations of multiorgan involvement in advanced prostate cancer","volume":"71","author":"Padhani","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2019.12.010_bib14","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/RLI.0000000000000579","article-title":"Quantitative assessment of bone metastasis in prostate cancer using synthetic magnetic resonance imaging","volume":"54","author":"Arita","year":"2019","journal-title":"Invest Radiol"},{"key":"10.1016\/j.clgc.2019.12.010_bib15","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.eururo.2017.06.002","article-title":"Management of patients with advanced prostate cancer: the report of the Advanced Prostate Cancer Consensus Conference APCCC 2017","volume":"73","author":"Gillessen","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2019.12.010_bib16","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.eururo.2018.03.030","article-title":"Impact of (68)Ga-PSMA PET on the management of patients with prostate cancer: a systematic review and meta-analysis","volume":"74","author":"Han","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2019.12.010_bib17","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.eururo.2018.11.050","article-title":"Can local ablative radiotherapy revert castration-resistant prostate cancer to an earlier stage of disease?","volume":"75","author":"Lohaus","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2019.12.010_bib18","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ijrobp.2019.06.011","article-title":"Progressive site-directed therapy for castration-resistant prostate cancer: localization of the progressive site as a prognostic factor","volume":"105","author":"Yoshida","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clgc.2019.12.010_bib19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/1097-0142(19880101)61:1<195::AID-CNCR2820610133>3.0.CO;2-Y","article-title":"Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan","volume":"61","author":"Soloway","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/j.clgc.2019.12.010_bib20","first-page":"164","article-title":"Metastatic carcinoma of the prostate: identifying prognostic groups using recursive partitioning","volume":"169","author":"Glass","year":"2003","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.clgc.2019.12.010_bib21","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0140-6736(10)61389-X","article-title":"Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial","volume":"376","author":"de Bono","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.clgc.2019.12.010_bib22","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1056\/NEJMoa1207506","article-title":"Increased survival with enzalutamide in prostate cancer after chemotherapy","volume":"367","author":"Scher","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clgc.2019.12.010_bib23","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/pcan.2013.41","article-title":"Exploratory analysis of the visceral disease subgroup in a phase III study of abiraterone acetate in metastatic castration-resistant prostate cancer","volume":"17","author":"Goodman","year":"2014","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.clgc.2019.12.010_bib24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1148\/radiol.2015150799","article-title":"Volume of bone metastasis assessed with whole-body diffusion-weighted imaging is associated with overall survival in metastatic castration-resistant prostate cancer","volume":"280","author":"Perez-Lopez","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.clgc.2019.12.010_bib25","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1148\/radiol.2016160646","article-title":"Diffusion-weighted imaging as a treatment response biomarker for evaluating bone metastases in prostate cancer: a pilot study","volume":"283","author":"Perez-Lopez","year":"2017","journal-title":"Radiology"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767319303830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767319303830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:32:47Z","timestamp":1761564767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767319303830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S1558767319303830"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2019.12.010","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"METastasis Reporting and Data System for Prostate Cancer as a Prognostic Imaging Marker in Castration-resistant Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2019.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}